Journal Information

Statistics

Follow this link to access the full text of the article

IMPACTO FINANCEIRO DE ACALABRUTINIBE COMPARADO COM IBRUTINIBE NO TRATAMENTO DE LINFOMA DE CÉLULAS DO MANTO (LCM) RECIDIVADO OU REFRATÁRIO (RR) NA PERSPECTIVA DO SISTEMA DE SAÚDE SUPLEMENTAR BRASILEIRO
LYC Garciaa, GN Ribeirob, RS Tavaresc, KP Vianaa, GT Silvaa, AF Marinatod, JV Pinto-Netoe
a AstraZeneca do Brasil
b Hospital das Clínicas, Universidade Federal de Minas Gerais (UFMG), Belo Horizonte, MG, Brasil
c Hospital das Clínicas, Universidade Federal de Goiás (UFG), Goiânia, GO, Brasil
d Grupo Viva, Novo Hamburgo, RS, Brasil
e Centro de Câncer de Brasília (Cettro), Brasília, DF, Brasil
Read
1649
Times
was read the article
947
Total PDF
702
Total HTML
Share statistics
Article information
ISSN: 25311379
Original language: English
The statistics are updated each day
Year/Month Html Pdf Total
2025 May 21 11 32
2025 April 27 12 39
2025 March 33 8 41
2025 February 22 17 39
2025 January 31 15 46
2024 December 23 14 37
2024 November 28 27 55
2024 October 19 34 53
2024 September 17 25 42
2024 August 26 28 54
2024 July 16 24 40
2024 June 18 19 37
2024 May 21 25 46
2024 April 19 17 36
2024 March 17 24 41
2024 February 18 22 40
2024 January 15 26 41
2023 December 15 24 39
2023 November 28 30 58
2023 October 18 29 47
2023 September 18 35 53
2023 August 14 14 28
2023 July 23 15 38
2023 June 13 11 24
2023 May 15 25 40
2023 April 9 6 15
2023 March 10 16 26
2023 February 7 13 20
2023 January 9 4 13
2022 December 10 15 25
2022 November 13 22 35
2022 October 12 28 40
2022 September 16 31 47
2022 August 8 20 28
2022 July 9 30 39
2022 June 15 48 63
2022 May 11 25 36
2022 April 7 23 30
2022 March 14 17 31
2022 February 8 33 41
2022 January 8 30 38
2021 December 9 16 25
2021 November 9 20 29
2021 October 3 19 22
Show all

Follow this link to access the full text of the article

Idiomas
Hematology, Transfusion and Cell Therapy